CO News and Press, Global Cord Blood Corporation From 01/05/21

Global Cord Blood ([[CO]] +0.7%) reports that China's National Health Commission or NHC has issued a new policy stating that no applications for cord blood banking licenses in China will be accepted in 2021.In order to improve public health and medical safety and for ...

Global Cord Blood Announces NHC Policy Update PR Newswire HONG KONG , Jan. 5, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell process...

Without a doubt, 2020 has been a unique year, with many challenges for investors in both markets and personal lives. 2020 has been a very volatile year, however I managed to achieve a total return of 49.2% over the year across seven different strategies (US and Canadian), all beating ...

In the past month, dividend stocks and dividend growth stocks have once again underperformed the market.Over the last month, the worst performing U.S. equity factors are High Dividend Yield -0.7%, Value -0.2% and Dividend Growth -0.1%. Compare them to: Momentum +...

Global Cord Blood Corporation Announces Results of 2020 Annual General Meeting HONG KONG , Dec. 7, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testi...

CO is a market leader with more net cash than the market cap and our price target is $6.00 [45% upside]. 1HFY2021 results saw total subscriber numbers grow by 10%, despite tough operating conditions. CO's mark-to-market gains and cost cutting efficiency saw a decent September quar...

Image source: The Motley Fool. Global Cord Blood Corporation (NYSE: CO) Q2 2021 Earnings Call Nov 25, 2020 , 8:00 a.m. ET Operator Continue reading For further details see: Global Cord Blood Corporation (CO) Q2 2021 Earnings Call Transcri...

Global Cord Blood Corporation (CO) Q2 2021 Results Earnings Conference Call November 25, 2020, 8:00 AM ET Company Participants Cathy Bai - Vice President, Corporate Finance Ting Zheng - Chairman and CEO Albert Chen - Chief Financial Officer Conference Call Participants Jeff Oliver - Lone Star...

Global Cord Blood (CO): FQ2 GAAP EPS of $0.16.Revenue of $42.07M (-4.1% Y/Y)Press Release For further details see: Global Cord Blood reports FQ2 results

Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2021 Added 17,643 New Subscribers in 2Q21 Conference Call to be Held on November 25, 2020, at 8:00 a.m. ET PR Newswire HONG KONG, Nov. 24, 2020 HONG KONG...